Testing effectiveness (Phase 2)Ended earlyNCT03331445
What this trial is testing
Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections
Who this might be right for
Respiratory Tract InfectionsCorona Virus Infection
Chris Miller 13